Australia markets closed

Repligen Corporation (RGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
188.46-1.12 (-0.59%)
At close: 04:00PM EST
188.20 -0.26 (-0.14%)
After hours: 05:34PM EST
Full screen
Trade prices are not sourced from all markets
Previous close189.58
Bid0.00 x 900
Ask0.00 x 800
Day's range188.37 - 196.01
52-week range162.29 - 327.32
Avg. volume433,255
Market cap10.42B
Beta (5Y monthly)0.77
PE ratio (TTM)89.70
EPS (TTM)2.10
Earnings date22 Feb 2022 - 28 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est312.56
  • Motley Fool

    2 Healthcare Stocks That Could Help Set You Up for Life

    Repligen (NASDAQ: RGEN) and ResMed (NYSE: RMD) are two stocks which could fit that bill with their proven track records and growing opportunities. Repligen offers a unique way to invest in the healthcare space. Operating in both the downstream and upstream processes of drug development, Repligen sells products in the areas of filtration, chromatography, process analytics, and proteins.

  • Zacks

    Gamida (GMDA) Up on Omidubicel BLA Rolling Submission Plan

    The FDA agrees to the initiation of rolling submission of Gamida's (GMDA) BLA for its lead blood cancer candidate, omidubicel. The stock rises more than 22% on in response.

  • Motley Fool

    These Are 5 of the Fastest-Growing Large-Cap Stocks on the Planet

    If you've got the time and intestinal fortitude to deal with a stock's big ups and downs, a big potential payoff awaits. If you think Advanced Micro Devices (NASDAQ: AMD) is always behind Nvidia in the graphics card market while at the same time perpetually playing second fiddle to Intel within the computer processor arena, you're right. Namely, Advanced Micro Devices' hardware is a favorite among hardcore video gamers because it's affordable without sacrificing performance.